To purchase hard copies of this book, please email:
orders@intechopen.com
Share this page
This book is indexed in
Pharmacology, Toxicology and Pharmaceutical Science » Pharmacology
Drug Discovery and Development - Present and Future
Edited by Izet M. Kapetanovic, ISBN 978-953-307-615-7, Hard cover, 528 pages, Publisher: InTech, Chapters published December 16, 2011 under CC BY 3.0 license
DOI: 10.5772/1179
Drug discovery and development process aims to make available medications that are safe and effective in improving the length and quality of life and relieving pain and suffering. However, the process is very complex, time consuming, resource intensive, requiring multi-disciplinary expertise and innovative approaches. There is a growing urgency to identify and develop more effective, efficient, and expedient ways to bring safe and effective products to the market. The drug discovery and development process relies on the utilization of relevant and robust tools, methods, models, and validated biomarkers that are predictive of clinical effects in terms of diagnosis, prevention, therapy, and prognosis. There is a growing emphasis on translational research, a bidirectional bench to the bedside approach, in an effort to improve the process efficiency and the need for further innovations. The authors in the book discuss the current and evolving state of drug discovery and development.
- Introductory Chapter
Overview of Current Drug Discovery and Development with an Eye towards the Future - Chapter 1
Drug Discovery and Ayurveda: Win-Win Relationship Between Contemporary and Ancient Sciences - Chapter 2
Evolutionary Biology and Drug Development - Chapter 3
Novel Oncology Drug Development Strategies in the Era of Personalised Medicine - Chapter 4
Drug Discovery into the 21st Century - Chapter 5
Genetically Engineered Mouse Models in Preclinical Anti-Cancer Drug Development - Chapter 6
Genetic Pharmacotherapy - Chapter 7
Critical Human Hepatocyte-Based In Vitro Assays for the Evaluation of Adverse Drug Effects - Chapter 8
The Use of In Vitro 3D Cell Models in Drug Development for Respiratory Diseases - Chapter 9
Chemical Biology: What is Its Role in Drug Discovery? - Chapter 10
Towards Understanding Drugs on the Molecular Level to Design Drugs of Desired Profiles - Chapter 11
De-Risking Drug Discovery Programmes Early with ADMET - Chapter 12
Novel Approach to High Throughput Screening for Activators of Transcription Factors - Chapter 13
Assessment of Cell Cycle Inhibitors by Flow Cytometry - Chapter 14
Image-Based High-Content Screening in Drug Discovery - Chapter 15
Recent Advances in Biotherapeutics Drug Discovery and Development - Chapter 16
Drug Discovery by Aptamers in Protozoan Infectious Diseases - Chapter 17
Streamlining ICH Q6B Analytical Testing of Biotherapeutics - Chapter 18
Biomarkers in Drug Development: A Useful Tool but Discrepant Results May Have a Major Impact - Chapter 19
Nanotechnology Based Targeted Drug Delivery: Current Status and Future Prospects for Drug Development - Chapter 20
Silver Nanoparticles – Universal Multifunctional Nanoparticles for Bio Sensing, Imaging for Diagnostics and Targeted Drug Delivery for Therapeutic Applications - Chapter 21
Mesenchymal Stem Cells as Vehicles for Targeted Therapies
